In addition, by targeting mTORC1 and decreasing the frequency of CD4+ CTLs, rapamycin ameliorated diplopia and orbital inflammation in patients with intractable GO (Zhang et al., 2023). This evidence concerns the gene CD4 and geroderma osteodysplastica.